Literature DB >> 3494037

Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis.

V Fonseca, O Epstein, D S Gill, R K Menon, M Thomas, N McIntyre, P Dandona.   

Abstract

Thirty-six patients with primary biliary cirrhosis (PBC) receiving calcium and calciferol supplements (100,000 IU monthly by im injection) were investigated for their calcium, vitamin D, PTH, and osteocalcin status. The corrected plasma calcium concentrations in PBC patients were significantly greater than those in normal subjects. While the mean serum 25-hydroxycholecalciferol and 1,25-dihydroxyvitamin D concentrations in these patients were similar to those in normal subjects, the mean serum PTH concentration was significantly greater, and it was supranormal in 11 patients. Three patients had elevated corrected calcium concentrations; 1 of them had a concomitant increase in ionized calcium and a supranormal PTH level, and another had a high normal PTH. Ionized calcium concentrations were normal in the rest. Serum osteocalcin concentrations were significantly lower in the patients compared with those in normal subjects. These results indicate that PTH concentrations are frequently elevated in PBC patients despite adequate vitamin D supplementation and normal or even supranormal plasma calcium concentrations. Nonsuppression of PTH concentrations and autonomy of PTH secretion suggest that vitamin D deficiency and secondary hyperparathyroidism in such patients probably occur much earlier in the natural history of this disease than is currently realized. Persistent nonsuppressible hypersecretion of PTH probably contributes to the bone disease of primary biliary cirrhosis. The low osteocalcin concentrations probably reflect diminished osteoblastic activity, which may also contribute to osteopenia in these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494037     DOI: 10.1210/jcem-64-5-873

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.

Authors:  Karam A Mahdy; Hanaa H Ahmed; Fathia Mannaa; Azza Abdel-Shaheed
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

3.  Prolonged vitamin D deficiency and autonomous hyperparathyroidism.

Authors:  V A Fonseca; M Thomas; D S Gill; P Dandona
Journal:  BMJ       Date:  1989-09-02

4.  Amount and composition of bone minerals in chronic liver disease.

Authors:  J A Kalef-Ezra; M H Merkouropoulos; A Challa; J Hatzikonstantinou; A H Karantanas; E V Tsianos
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

5.  Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa.

Authors:  V A Fonseca; V D'Souza; S Houlder; M Thomas; A Wakeling; P Dandona
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

6.  Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

Authors:  Ali Gur; Bünyamin Dikici; Kemal Nas; Mehmet Bosnak; Kenan Haspolat; Aysegul Jale Sarac
Journal:  BMC Gastroenterol       Date:  2005-09-19       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.